YIELD10 BIOSCI Cash Flow - Quarterly (NASDAQ:YTEN)
$2.28 $0.07 (2.98%) YTEN stock closing price Aug 18, 2017 (Closing)
The YIELD10 BIOSCI cash flow statement helps investors understand how well the company is managing its cash flows. In simple terms, the cash flow statement measures the cash that has come into the company, and the cash that has gone out during a given period, while the other statements, the income statement and balance sheet, give details about YIELD10 BIOSCI profits and YIELD10 BIOSCI debt. Items like capital purchases, bank loan payments etc. which have a direct impact on the cash position of a company come out through the statemement of cash flows and help an investor who undertakes the YIELD10 BIOSCI stock analysis. YIELD10 BIOSCI generated $-4.29M cash from operating activities in 2017-Q2. View details of YIELD10 BIOSCI cash flows for latest & last 40 quarters.
show more
| Fiscal year is Jan - Dec. | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | 2015 Q4 | 2015 Q3 | 2015 Q2 | 2015 Q1 |
YIELD10 BIOSCI Net Income Cash Flow | -4.82M | -2.09M | -7.6M | -5.67M | -9.69M | -6.49M | -23.68M | -17.76M | -11.91M | -5.84M |
| Depreciation Depletion Amortization Cash-Flow | 0.11M | 0.05M | 0.51M | 0.45M | 0.27M | 0.12M | 0.26M | 0.16M | 0.1M | 0.05M |
| Net Increase (Decrease) in Assets Liabilities | -0.28M | -0.68M | 0.69M | 0.75M | 0.43M | -0.89M | -1.07M | -0.73M | -1.42M | -1.32M |
| Cash From (used in) Discontinued Operations | - | - | -9.83M | -9.83M | - | - | - | - | - | - |
| Other Adjustments Net | 0.71M | 0.28M | 1.52M | 2.02M | 1.1M | 0.74M | 2.62M | 1.94M | 1.11M | 0.45M |
YIELD10 BIOSCI Net Cash from (used by) Operating Activities | -4.29M | -2.43M | -14.7M | -12.26M | -7.89M | -6.52M | -21.86M | -16.39M | -12.12M | -6.66M |
| Increase (Decrease) in Prop Plant And Equipment | - | - | -0.75M | -0.72M | -0.35M | -0.16M | -0.61M | -0.45M | -0.2M | -0.12M |
| Acquisition Disposition of Subsidiaires | - | - | - | - | - | - | - | - | - | - |
| Increase (Decrease) in Investments | - | - | - | - | - | - | - | - | - | - |
| Other Cash Inflow (Outflow) from Investment Activities | - | - | 10.5M | 10.5M | -0.3M | -0.3M | - | - | - | - |
YIELD10 BIOSCI Net Cash from (used by) Invesment Activities | - | - | 9.75M | 9.78M | -0.66M | -0.46M | -0.61M | -0.45M | -0.2M | -0.12M |
| Issuance (Purchase) of Equity Shares | - | - | - | - | - | - | 14.7M | 14.7M | 15M | - |
| Issuance (Repayment) of Debt Securities | - | - | - | - | - | - | - | - | - | - |
| Increase (Decrease) in Bank & Other Borrowings | - | - | - | - | - | - | - | - | - | - |
| Payment of Dividends & Other Cash Distributions | - | - | - | - | - | - | - | - | - | - |
| Other Cash from (used by) Financing Activities | -0.01M | - | - | - | - | - | - | - | - | - |
YIELD10 BIOSCI Net Cash from (used by) Financing Activities | -0.01M | - | - | - | - | - | 14.7M | 14.7M | 15M | - |
| Effect of Exchange Rate Changes on Cash | - | - | -0.01M | -0.01M | -0.01M | - | - | - | - | - |
YIELD10 BIOSCI Net Change in Cash & Cash Equivalents | -4.3M | -2.43M | -4.96M | -2.48M | -8.56M | -6.99M | -7.77M | -2.15M | 2.66M | -6.78M |
| Cash & Equivalents at Beginning of Year | 12.26M | 20.04M | 7.69M | 14.57M | 21.27M | 12.52M | 10.81M | 26.19M | 22.68M | 25.18M |
| Cash & Equivalents at Year End | 3.01M | 4.87M | 7.3M | 9.78M | 3.7M | 5.27M | 12.26M | 17.89M | 22.7M | 13.25M |
All figures in USD. M: Millions of USD, B: Billions of USD.
View Next Quarters
Click here to view our Google financial analysis, Amazon financial analysis, Facebook financial analysis
YIELD10 BIOSCI stock price history provides insight into historical stock price fluctuations, and YIELD10 BIOSCI stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:
- YIELD10 BIOSCI had a Net Change in Cash and Cash Equivalents of $-4.3M for the latest quarter 2017-Q2. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the YIELD10 BIOSCI stock price , albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
- YIELD10 BIOSCI decreased its cash from operating activities to $1.86M in 2017-Q2. Operating activities include production of goods or creating a product or providing a service, and collecting payment for the same from customers. The cash generated from these activities is refered to as cash flow from operating activities. It includes the use of cash outside of normal day to day activities like buying fixed assets, plant and machinery etc.
- Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $-0.01M for YIELD10 BIOSCI.
Key Financial Ratios For YIELD10 BIOSCI Cash Flow
FCF margin
-7.59